|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
Last
Updated:
13-Sep-2009 |
|
| |
Licensing
technologies and commercialization
July 14 2009
Yissum Research
Development Company of
the Hebrew University of Jerusalem Ltd., the technology transfer arm of
the University, announced that it has licensed a novel package of stem
cell related technologies to TheraCell, Inc. (California, USA), which
will further develop and commercialize the technology for advanced
regenerative medicine procedures such as spinal fusion. The technology
was invented by a team headed by Professor Dan Gazit
from the Faculty of Dental Medicine at the Hebrew University of
Jerusalem.
Related press releases:
|
|
|
-
Composite
scaffolds and methods using same for
generating complex tissue grafts - US patent application 20040203146,
Pending.
-
Methods
of inducing or enhancing cartilage
repair – US patent 6,849,255; European patent 0995795.
-
Methods
of inducing or enhancing connective
tissue repair - US patent application 20030228292, granted.
-
Systems
and methods for analyzing and
manipulating biological samples - PCT, 2006.
-
Methods
of implanting mesenchymal stem cells
for tissue repair and formation – US patent application
20080112936, pending.
-
Genetically
engineered cells which express
bone morphogenetic proteins - US patent application 20020102728,
pending. European patent 1007559.
-
Scaffolds
with oxygen carriers, and their use
in tissue regeneration – PCT, 2009.
- Method for
targeted delivery of bioactive
molecules for tissue regeneration – Provisional patent 2009.
|
|
|
